| Date Filed | Type | Description |
| 07/18/2023 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Sold 689 shares
@ $3.5, valued at
$2.4k
|
|
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 623 shares
@ $2.58, valued at
$1.6k
Exercised 2,000 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 44,500 options to buy
@ $6.73, valued at
$299.5k
Granted 34,000 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 27,266 shares
@ $1.12, valued at
$30.5k
|
|
| 02/17/2022 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.59, valued at
$159k
Granted 80,000 restricted stock units
@ $0
Granted 200,000 restricted stock units
@ $0 |
|
| 01/06/2022 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Sold 2,208 shares
@ $3.4669, valued at
$7.7k
|
|
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2020 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Sold 4,963 shares
@ $13, valued at
$64.5k
Sold 10,787 shares
@ $13, valued at
$140.2k
Exercised 4,963 options to buy
@ $1.01, valued at
$5k
Exercised 10,787 options to buy
@ $1.01, valued at
$10.9k
|
|
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2018 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 75,000 options to buy
@ $10.09, valued at
$756.8k
|
|
| 08/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/29/2016 |
3
| Olson Eric R (Chief Scientific Officer) has filed a Form 3 on Syros Pharmaceuticals, Inc. |